Wireless Prosthetic Control Effectiveness Study
Launched by LIBERATING TECHNOLOGIES, INC. · Feb 10, 2025
Trial Information
Current as of August 25, 2025
Recruiting
Keywords
ClinConnect Summary
The Wireless Prosthetic Control Effectiveness Study is looking at a new wireless electrode system called the ASTERISK, designed to improve the experience for people using prosthetic arms below the elbow. This study aims to determine how effective this innovative system is for users, as it could lead to better comfort, fit, and control of prosthetic devices. With wireless technology, it will be easier for users to manage their prostheses, especially those who have had surgery to integrate the prosthesis into their body.
To participate in this study, you need to currently use a myoelectric prosthesis—this means it is controlled by your muscle signals— and have been using it for at least six months. You should be able to understand English to help with the consent process. Unfortunately, if you have certain neurological or physical issues that could interfere with the tasks you'll be asked to do, or if you're pregnant, you won't be eligible. If you join the study, you can expect to contribute to important research that could shape future prosthetic designs, ultimately benefiting others in the prosthetic community.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • current wearers of trans-radial myoelectric prostheses or orthoses
- • have used their prostheses/orthoses for at least six months
- • understand spoken and written English (for the purpose of consenting)
- Exclusion Criteria:
- • have any neurological or physical conditions which would prevent them from performing the experimental tasks
- • are pregnant
About Liberating Technologies, Inc.
Liberating Technologies, Inc. is an innovative clinical trial sponsor dedicated to advancing medical research and improving patient outcomes through the development of cutting-edge technologies. Focused on enhancing the quality of life for individuals with mobility challenges, the company leverages its expertise in robotics and rehabilitation to design and implement clinical trials that evaluate the efficacy and safety of novel therapeutic solutions. With a commitment to collaboration and transparency, Liberating Technologies aims to foster partnerships with healthcare professionals, researchers, and regulatory bodies, ensuring that their studies are conducted with the highest standards of integrity and scientific rigor.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Holliston, Massachusetts, United States
Patients applied
Trial Officials
Benjamin McDonald
Principal Investigator
Liberating Technologies, Inc.
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported